Evaluation of the efficacy of oral agar gel administration on prevention of non hemolytic jaundice in normal term neonates; a double blind controlled trial
Phase 3
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT138811133250N1
- Lead Sponsor
- Kerman University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
healthy, term infant with birth weight more than 2500 grams
Exclusion criteria: Infants with infection, ABO or Rh incompatibility, G6PD deficiency and signs of lethargy or poor feeding
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum bilirubin level. Timepoint: First day of life, third and 5th days of life after intervention. Method of measurement: JM103- skin jaundicometer.
- Secondary Outcome Measures
Name Time Method